|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| A61K 48/00 | |||
| A61K 31/7088 |
| (11) | Number of the document | 3103872 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16166821.5 |
| Date of filing the European patent application | 2013-07-12 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261670681 P | 2012-07-12 | US | |
| 201261718801 P | 2012-10-26 | US | |
| 13166465 | 2013-05-03 | EP | |
| 13172515 | 2013-06-18 | EP | |
| 13173818 | 2013-06-26 | EP |
| (72) |
DE BOER, Daniel Anton, NL
RITSEMA, Tita, NL
|
| (73) |
ProQR Therapeutics II B.V.,
Zernikedreef 9, 2333 CK Leiden,
NL
|
| (54) | OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL |
| OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL |